KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Non-cash Items (2016 - 2024)

Historic Non-cash Items for Dynavax Technologies (DVAX) over the last 13 years, with Q2 2024 value amounting to $14.9 million.

  • Dynavax Technologies' Non-cash Items rose 12298.73% to $14.9 million in Q2 2024 from the same period last year, while for Jun 2024 it was $14.9 million, marking a year-over-year increase of 12298.73%. This contributed to the annual value of $7.0 million for FY2023, which is 5694.56% down from last year.
  • Per Dynavax Technologies' latest filing, its Non-cash Items stood at $14.9 million for Q2 2024, which was up 12298.73% from $23.0 million recorded in Q1 2024.
  • In the past 5 years, Dynavax Technologies' Non-cash Items ranged from a high of $46.6 million in Q3 2023 and a low of $616000.0 during Q4 2020
  • In the last 5 years, Dynavax Technologies' Non-cash Items had a median value of $9.4 million in 2023 and averaged $14.0 million.
  • In the last 5 years, Dynavax Technologies' Non-cash Items plummeted by 7101.18% in 2020 and then surged by 684090.91% in 2021.
  • Over the past 5 years, Dynavax Technologies' Non-cash Items (Quarter) stood at $616000.0 in 2020, then soared by 6840.91% to $42.8 million in 2021, then crashed by 61.9% to $16.3 million in 2022, then plummeted by 56.95% to $7.0 million in 2023, then soared by 112.85% to $14.9 million in 2024.
  • Its last three reported values are $14.9 million in Q2 2024, $23.0 million for Q1 2024, and $7.0 million during Q4 2023.